openPR Logo
Press release

Pharma plants: new challenges for biological safety

03-29-2007 09:01 AM CET | Energy & Environment

Press release from: GMO-Safety.eu

Around the world, efforts are increasing to use genetically modified plants as production systems for vaccines or drugs. A number of plantmade pharmaceuticals (PMPs) are already undergoing clinical tests. In Germany, plans for a field trial with genetically modified peas to prevent infectious diseases in pigs have provoked heavy discussion.

Novel feed: Peas to combat infectious diseases
http://www.gmo-safety.eu/en/news/536.docu.html

For biological safety, the cultivation of plants that produce pharmaceutical substances poses completely new challenges. Pharma plants are not allowed to spread or enter the food and feed chain. In order to ensure that they don’t, science has developed different strategies. The Focus "Pharma Plants" on gmo-safety.eu provides interesting background information.

Focus Pharma Plants
http://www.gmo-safety.eu/en/focus/pharma_crops/

Topics:

Pharma plants: Status report
http://www.gmo-safety.eu/en/focus/pharma_crops/548.docu.html

Plants under lock and key: Physical containment
http://www.gmo-safety.eu/en/focus/pharma_crops/544.docu.html

Biological containment: Plants without pollen
http://www.gmo-safety.eu/en/gene_transfer/confinement/465.docu.html

Biological containment: Seeds that don’t germinate
http://www.gmo-safety.eu/en/gene_transfer/confinement/466.docu.html

Biological containment: Trees without blossom
http://www.gmo-safety.eu/en/focus/pharma_crops/546.docu.html

Biosafety project (2005-2008): Male-sterile plants prevent the spread of transgenes; University of Würzburg
http://www.gmo-safety.eu/en/safety_science/178.docu.html

**********************
GMO-Safety.eu - Biosafety research made transparent

The GMO-Safety.eu internet portal provides up-to-date, clear information about the research projects funded by the German Ministry of Education and Research (BMBF) on the biological safety of genetically modified plants. A comprehensive database with summaries of the research topics, methods and results is supplemented by background reports and interviews and insights into the day-to-day work of researchers. The portal makes the findings of biological safety research accessible to the general public and is intended to help people form an informed opinion. It is produced on behalf of the German Federal Ministry of Education and Research by the project partners Genius GmbH, Darmstadt; TransGen, Aachen and the TÜV Nord Group.

Contact:

GMO-Safety.eu Team

Genius GmbH
Science & Communication
Robert-Bosch-Str. 7
64293 Darmstadt
Germany

fon: ++49 (0) 6151 - 872 41 04
fax: ++49 (0) 6151 - 872 40 41
e-mail: press@gmo-safety.eu

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharma plants: new challenges for biological safety here

News-ID: 17594 • Views:

More Releases from GMO-Safety.eu

Biosafety of genetically modified plants: GMO-Safety.eu information portal brings transparency to biosafety research
Biosafety of genetically modified plants: GMO-Safety.eu information portal bring …
Does genetically modified maize have an impact on beneficial insects? How does genetically modified oilseed rape affect pollen-collecting bees? How can transgenic pollen and seeds be prevented from spreading in the environment? These are just some of the questions being investigated in biological safety research worldwide. Answers and research findings, which are otherwise usually made public only at scientific conferences and congresses, are accessible to the public at www.gmo-safety.eu. The information

More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the